share_log

恒瑞医药关于公司药物获得美国FDA快速通道资格的公告

Hengrui Pharmaceutical's Announcement on the Company's Drug Obtaining Fast Track Qualification from the US FDA

SZSI ·  Apr 18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more